AYTU Beats the Street-Possible Takeover Target?
* Highest revenue in company history. $14.9 Million ($5 million monthly)
That's $60 Million Annually!!!!
In 2019 AYTU averaged $610,000 monthly revenue or $7 Million Annually
That's an increase of 860%!!!
* EPS came in better than Analysts expectations
* 2.67 Current Ratio, ($75M Current Assets/28M Current Assets) which proves AYTU can easily meet short-term obligations.
* $50 Million in Rights/Patents/Tradenames
* $48 Million in Cash
* $95 Million in Stockholders Equity
* Healight is an attractive technology with the potential to become global.
* Healight technology will be altered to be used through the nose or mouth. This potential aspect could bring in hundreds of millions of dollars alone. Saving hospitals millions of dollars. This is important to hospitals, because it could help the patient heal faster, while driving down length of stay for older and ICU patients.
* AYTU is perfectly placed to offer Covid-19 testing and emergency approved by the FDA. This alone is very attractive to a major player such as Kodak.
* Multiple drug products on a global scale.
* Expected to be profitable in 2021
Conclusion:
Today was a major accomplishment for AYTU. Just a few months ago it was a penny stock. Today the company has proven it has a viable global business plan with multiple streams of revenue. Management has lofty goals for such a small company. But surprisingly, they're accomplishing their goals very quickly. As a result, their expenses are high. But this is typical for small company with lofty goals. Today management is earning creditability. I've taught business for many years at the graduate level. I've studied mergers and acquisitions for many years. I would not be surprised if AYTU is notified of a 13D being filed very soon. If I was a larger player in the market, I'd wait for the news on the Healight before I make a move.
